GANYMED Pharmaceuticals' Series E Round

GANYMED Pharmaceuticals raised a round of funding on November 18, 2013.

Ganymed Pharmaceuticals is a biopharmaceutical company that researches, develops, and produces pharmaceutical products and therapeutic drugs for the treatment of solid cancers. It focuses on developin…

Articles about GANYMED Pharmaceuticals' Series E Round: